Canine Cushing's Case Files: The ins and outs of detection and treatment—Case file: Mitch (Sponsored by Dechra Veterinary Products)
Aug 01, 2013
CUSTOM VETERINARY MEDIA
Whenever possible, pituitary-dependent hyperadrenocorticism and adrenal tumors should be differentiated to help guide therapy and patient monitoring. Early diagnosis and management of canine hyperadrenocorticism may not only improve the patient's clinical signs but may also keep the more severe consequences of Cushing's syndrome from developing.
CASE FILE: MITCH 12-year-old neutered male dachshund weighing 22 lb (10 kg)Patient history and initial diagnostic workup
Mitch was presented to his primary care veterinarian for evaluation of polyuria and polydipsia of six months' duration. The dog's urine specific gravity was 1.010 and a serum chemistry profile revealed an alkaline phosphatase activity of 1,240 IU/L (reference range 37 to 105 IU/L). The results of a complete blood count were within normal limits, and urine bacterial culture results were negative.
Adrenal function test results
The results of an adrenocorticotropic hormone (ACTH) stimulation test revealed a baseline cortisol concentration of 3.6 μg/dl (reference range = 1.4 to 5 μg/dl) and a one-hour post-ACTH cortisol concentration of 12.9 μg/dl (reference range = 5.5 to 20 μg/dl). Low-dose dexamethasone suppression (LDDS) test results revealed a resting cortisol concentration of 9.1 μg/dl (reference range 1.4 to 5 μg/dl) with four- and eight-hour post-dexamethasone cortisol concentrations of 5.6 μg/dl and 2.3 μg/dl (reference range < 1.4 μg/dl), respectively.